Dr. Ryan Donnelly from Queen’s University Belfast, United Kingdom will talk about “Microarray patches for prevention and treatment of infectious diseases and their potential for reducing antibiotic resistance” during the 5th World Congress on Targeting Infectious Diseases: Targeting Phage & Antibiotic Resistance 2018 which will be held on May 17-18, 2018 in Florence, Italy,
Accoding to him: “The human gut microbiome is a key source of antibiotic-resistance genes. Oral delivery of antibiotics contributes to development of resistance. Intravenous administration of renally-excreted antibiotics can minimise development of resistant bacteria in the gut and avoid disruption of the gut microbiome, preventing dysbiosis-associated health probolems. However, it is impractical to admit patients to hospital for intravenous treatment every time they need an antibiotic. Novel transdermal delivery systems can deliver antibiotics directly to the systemic circulation, bypassing the gut. We are currently developing such systems, with a view to extending the lifetime of existing antibiotics.”
Don’t hesitate to participate to Targeting Antibiotic Resistance Congress which will be held in Florence on May 17-18, 2018.
More information on www.tid-site.com/